Anti-cancer and Anti-obesity Cyclic Peptide Agents
This invention relates to a compound for anticancer and anti-obesity, and particularly, but not exclusively, a compound based on cyclic peptide agents for anticancer and anti-obesity.
Reducing the side effects
For use in anticancer or anti-obesity.
The present invention is based, at least in part, on the discovery that cyclopeptide compounds such as compounds isolated from the dry stem barks of the decayed woods of the plant Maytenus variabilis (Loes.) C. Y. Cheng (Celastraceae) are effective in the treatment of cancer and obesity diseases. Compounds of the invention may exist in different forms, such as free acids, free bases, enantiomers, esters and other prodrugs, salts and tautomers, for example, and the disclosure includes all variant forms of these compounds.
Inventor: Zhang, Hongjie
Priority Number: US20140107018A1
IPC Current: C07K000764
US Class: 5140048 | 5140193 | 530321 | 562506
Assignee Applicant: Hong Kong Baptist University
Title: ANTICANCER AND ANTI-OBESITY CYCLIC PEPTIDE AGENTS
Usefulness: ANTICANCER AND ANTI-OBESITY CYCLIC PEPTIDE AGENTS
Summary: (I) are useful alone or in combination with clinically used anticancer or anti-obesity agent for treating, preventing or delaying the of progression of cancer or obesity in a human (all claimed).
Novelty: New cyclopeptide compounds used anticancer or anti-obesity agent for treating, preventing or delaying the of progression of cancer or obesity
Disease Diagnostic/Treatment
Cancer/Tumor
2013.03.14
US 13/804,276
Filed
A61/ZH/Obes/US01
Hong Kong
